True Confessions: Bristol Exec Sentenced To Write A Book, But Can He Get Published?
Executive Summary
Former Bristol-Myers Squibb executive Andrew Bodnar may have escaped jail time for lying to the Federal Trade Commission, but he may suffer, nonetheless. Publishers and authors say his unusual sentence to write a book about his experience will bring plenty of pain and humiliation
You may also be interested in...
Apotex Plavix Saga May Finally Be Over; Judge Asks “What Is Going On In This Case?”
Apotex sought $3.4 billion in damages, claiming Bristol-Myers Squibb scuttled their patent settlement agreement by submitting a false certification to the FTC that it had no oral commitment not to sell an authorized generic of Plavix during Apotex’s exclusivity period; Apotex had told the FTC there was such a side deal.
Sanofi Set To Seek $442 Million From Apotex For Plavix Infringement
District court denies Apotex's request to stay the award of damages; Patent Office reexamination finds Plavix patent is valid.
Sanofi Set To Seek $442 Million From Apotex For Plavix Infringement
District court denies Apotex's request to stay the award of damages; Patent Office reexamination finds Plavix patent is valid.